LMRI
LMRI
NASDAQ · Health Care

Lumexa Imaging Holdings Inc

$10.21
+0.33 (+3.34%)
Financial Highlights (FY 2026)
Revenue
1.02B
Net Income
-47,086,345
Gross Margin
15.4%
Profit Margin
-4.6%
Rev Growth
—
D/E Ratio
1.50
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 15.4% 29.9% 29.9% 29.9%
Operating Margin 8.2% 10.0% 8.9% 11.0%
Profit Margin -4.6% 9.4% 11.2% 11.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.02B 375.11M 355.40M 343.46M
Gross Profit 157.50M 112.01M 106.13M 102.56M
Operating Income 84.37M 37.42M 31.55M 37.68M
Net Income -47,086,345 35.06M 39.68M 38.70M
Gross Margin 15.4% 29.9% 29.9% 29.9%
Operating Margin 8.2% 10.0% 8.9% 11.0%
Profit Margin -4.6% 9.4% 11.2% 11.3%
Rev Growth — +14.5% +3.2% +9.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 284.48M 232.85M 214.66M 235.06M
Total Equity 190.13M 384.64M 386.55M 339.94M
D/E Ratio 1.50 0.61 0.56 0.69
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 124.80M 45.61M 39.96M 37.77M
Free Cash Flow — 22.82M 26.29M 24.34M